---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-331488"
form_type: "8-K"
ticker: "MD"
cik: "0000893949"
company_name: "Pediatrix Medical Group, Inc."
filed_at: "2026-08-04T10:50:18+00:00"
generated_at: "2026-08-04T10:55:26.492838+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Pediatrix Q2 2026: Adjusted EPS $0.63, revenue $488M, reaffirms FY EBITDA $280-300M

## Summary
- Net revenue $487.8M, up 4.0% YoY; net income $39.8M ($0.49 diluted EPS) vs $39.3M ($0.46) YoY.
- Adjusted EPS $0.63 vs $0.53 YoY; Adjusted EBITDA $76.4M vs $73.2M YoY.
- Same-unit revenue up 1.9% (reimbursement +4.0%, volume -2.1%); NICU days down 3.2%.
- Reaffirmed FY 2026 Adjusted EBITDA guidance of $280M-$300M.
- Used $42.7M for share repurchases in Q2; total debt $584M, cash $288.9M.

## SEC filing metadata
- accession: 0001193125-26-331488
- form_type: 8-K
- ticker: MD
- cik: 0000893949
- company_name: Pediatrix Medical Group, Inc.
- filed_at: 2026-08-04T10:50:18+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/893949/000119312526331488/0001193125-26-331488-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/893949/000119312526331488/md-20260804.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-331488
- JSON: https://secwatch.observer/filing/0001193125-26-331488.json
- Plain text: https://secwatch.observer/filing/0001193125-26-331488.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.